Bundling Rules: Keep an Eye on NCCI When Billing Thyroid FNA Cases

Why This Topic Matters

Thyroid FNA claims can be affected by bundling and unit-reporting rules, so understanding the article’s scope helps reduce avoidable billing errors and align documentation review with current policy guidance.

Article Sections

1. Case 1: Guidance, Lesion(s) Focus Code Selection

   Discusses thyroid FNA case variations involving imaging guidance and the number of separately identifiable lesions. It also introduces the related CPT code families and documentation focus for these scenarios.

2. Count lesions

   Explains the general need to track the number of lesions when reviewing FNA documentation. The section ties lesion identification to correct unit reporting and code-family selection.

3. Documentation advice

   Covers the importance of clear operative reporting and the risks of vague specimen documentation. It frames how wording in the record can affect coding accuracy for needle procedures.

4. NCCI guidance

   Summarizes the article’s discussion of NCCI Policy Manual language relevant to fine needle aspiration biopsy. The section focuses on policy context for distinct lesions and unit-of-service interpretation.

5. Case 2: Beware of ‘Passes’

   Addresses repeat sampling from the same lesion and how multiple passes are discussed in relation to reporting. It also transitions to a scenario involving a different biopsy procedure at the same encounter.

6. Payer alert

   Notes that payer policies may differ from NCCI-based guidance and encourages verification with individual payers. The section highlights variability in how bundled or combined services may be handled.